Republic Of Korea to India: Rituximab Import Trade Route
India has recorded 4 verified shipments of Rituximab imported from Republic Of Korea, representing a combined trade value of $28.6K USD. This corridor is served by 1 active Republic Of Korea exporters, with an average shipment value of $7.2K USD. The leading Republic Of Korea supplier is ZUELLIG PHARMA SPECIALTY, which accounts for 100% of total import value with 4 shipments worth $28.6K USD. On the buying side, DR.REDDY'S LABORATORIES LTD is the largest Indian importer with $28.6K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.
Route Intelligence Overview
The Republic Of Korea to India Rituximab corridor is one of India's established pharmaceutical import routes from Republic Of Korea, with 4 shipments documented worth a combined $28.6K USD. The route is dominated by ZUELLIG PHARMA SPECIALTY, which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Republic Of Korea's rituximab export sector.
Across 1 active Republic Of Korea suppliers, the average shipment value stands at $7.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with rituximab's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 32.3%, placing it at rank #14 among India's top rituximab import origins globally.
On the Indian buyer side, key Indian importers include DR.REDDY'S LABORATORIES LTD. DR.REDDY'S LABORATORIES LTD is the single largest Indian importer with 4 shipments valued at $28.6K USD.
Route Characteristics
- Average transit21 days
- Peak seasonQ3
- Primary modeSea freight
- Top port of entryHYDERABAD ACC (INHYD4)
Market Position
- Global rank#14
- Annual growth+32.3%
- Demand growth+28.8%
- Regulatory ease76/100
Top 10 Rituximab Exporters from Republic Of Korea to India
Showing top 10 of 1 Republic Of Korea suppliers exporting Rituximab to India, ranked by total trade value (USD)
| Rank | Supplier (Republic Of Korea Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ZUELLIG PHARMA SPECIALTY Avg $7.2K per shipment | 4 | $28.6K | 100.0% |
This table shows the top 10 of 1 Republic Of Korea companies exporting rituximab to India, ranked by total trade value. The listed exporters are: ZUELLIG PHARMA SPECIALTY. ZUELLIG PHARMA SPECIALTY is the dominant supplier with 4 shipments worth $28.6K USD, giving it a 100% market share.
Top 10 Indian Rituximab Importers from Republic Of Korea
Showing top 10 of 1 known Indian buyers receiving Rituximab shipments from Republic Of Korea, ranked by import value
On the receiving end of this trade route, the leading Indian importers of Republic Of Korea rituximab include DR.REDDY'S LABORATORIES LTD. The largest importer is DR.REDDY'S LABORATORIES LTD, accounting for $28.6K USD across 4 shipments — representing 100% of all rituximab imports from Republic Of Korea on this route.
| Rank | Indian Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LTD | 4 | $28.6K | 100.0% |
Top 10 Rituximab Formulations Imported from Republic Of Korea
Showing top 10 of 4 product formulations shipped on the Republic Of Korea to India Rituximab route, ranked by trade value
India imports a wide range of rituximab formulations from Republic Of Korea, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — MABTHERA (RITUXIMAB) INJECTION 500MG(MABINJ09KR-1) MABTHERA (RITUXIMAB) INJECTION 500MG(MABINJ09KR-1) — accounts for $14.0K USD across 1 shipments. A total of 4 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MABTHERA (RITUXIMAB) INJECTION 500MG(MABINJ09KR-1) MABTHERA (RITUXIMAB) INJECTION 500MG(MABINJ09KR-1) | 1 | $14.0K | 48.7% |
| 2 | MABTHERA (RITUXIMAB) INJECTION 500MG(MABINJ09KR) MABTHERA (RITUXIMAB) INJECTION 500MG(MABINJ09KR) | 1 | $11.3K | 39.6% |
| 3 | MABTHERA (RITUXIMAB) INJECTION 100MG(MABINJ10KR) MABTHERA (RITUXIMAB) INJECTION 100MG(MABINJ10KR) | 1 | $1.7K | 5.8% |
| 4 | MABTHERA (RITUXIMAB) INJECTION 100MG(MABINJ10KR-1) MABTHERA (RITUXIMAB) INJECTION 100MG(MABINJ10KR-1) | 1 | $1.7K | 5.8% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Indian Ports of Entry
HYDERABAD ACC (INHYD4) handles the highest volume with 4 shipments. Transit time averages 21 days by sea.
Market Dynamics
India's rituximab imports from Republic Of Korea are driven primarily by a handful of large-scale Republic Of Korea manufacturers. ZUELLIG PHARMA SPECIALTY with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Republic Of Korea supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ZUELLIG PHARMA SPECIALTY — together account for 100% of total trade value on this route. The average shipment value of $7.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as mabthera (rituximab) injection 500mg(mabinj09kr) mabthera (rituximab) injection 500mg(mabinj09kr) and mabthera (rituximab) injection 100mg(mabinj10kr) mabthera (rituximab) injection 100mg(mabinj10kr), suggesting that Indian buyers tend to consolidate orders across related product lines from the same Republic Of Korea supplier.
On the buying side, DR.REDDY'S LABORATORIES LTD is the largest importer with 4 shipments worth $28.6K USD — representing 100% of all rituximab imports from Republic Of Korea on this route.
Route Statistics
- Trade Volume
- $28.6K
- Avg. Shipment
- $7.2K
- Suppliers
- 1
- Buyers
- 1
- Transit (Sea)
- ~21 days
- Annual Growth
- +32.3%
Other Rituximab Routes
Unlock the Full Republic Of Korea to India Rituximab Dataset
TransData Nexus provides verified shipment-level records, exporter contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 4 shipments on this route.
Frequently Asked Questions — Republic Of Korea to India Rituximab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Republic Of Korea companies export Rituximab to India?
The leading Republic Of Korea exporters of Rituximab to India are ZUELLIG PHARMA SPECIALTY. ZUELLIG PHARMA SPECIALTY holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Rituximab imports from Republic Of Korea to India?
India imports Rituximab from Republic Of Korea worth approximately $28.6K USD across 4 recorded shipments. The average value per shipment is $7.2K USD.
Q Which Indian ports receive Rituximab from Republic Of Korea?
The most active Indian port of entry is HYDERABAD ACC (INHYD4) with 4 shipments. Republic Of Korea exporters primarily use sea freight for this route, with 74% of shipments going by sea and 21% by air.
Q How long does shipping take from Republic Of Korea to India for Rituximab?
The average transit time for Rituximab shipments from Republic Of Korea to India is approximately 21 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the Republic Of Korea to India Rituximab import route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 32.3% with demand growth tracking at 28.8%. The route is ranked #14 among India's top Rituximab import origins globally.
Q How many Republic Of Korea suppliers are active on this Rituximab import route?
There are currently 1 active Republic Of Korea suppliers exporting Rituximab to India. The market is moderately concentrated with ZUELLIG PHARMA SPECIALTY accounting for 100% of total shipment value.
Q Who are the main Indian importers of Rituximab from Republic Of Korea?
The leading Indian importers of Rituximab from Republic Of Korea include DR.REDDY'S LABORATORIES LTD. DR.REDDY'S LABORATORIES LTD is the largest buyer with 4 shipments worth $28.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Republic Of Korea export trade corridor identified from Indian Customs (DGFT) records for Rituximab.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 1 importers in Republic Of Korea matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 4 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists